Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
15.32
-0.20 (-1.29%)
At close: Sep 2, 2025, 4:00 PM
15.40
+0.08 (0.52%)
After-hours: Sep 2, 2025, 7:17 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.84 billion as of September 2, 2025. Its market cap has increased by 84.88% in one year.
Market Cap
1.84B
Enterprise Value
1.76B
1-Year Change
84.88%
Ranking
Category
Stock Price
$15.32
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.84B, an increase of 134.89%. That is a compound annual growth rate of 16.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 1.84B | 12.67% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |